Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer Growth.

Hintz HM, Snyder KM, Wu J, Hullsiek R, Dahlvang JD, Hart GT, Walcheck B, LeBeau AM
Cancer Immunol Res. 2021 Nov;9(11):1270-1282. doi: 10.1158/2326-6066.CIR-21-0178. Epub 2021 Aug 27. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.